Researchers in Japan have identified a genetic mutation that causes a severe lung disease called idiopathic pulmonary fibrosis (IPF) by killing the cells lining the lung's airways. The study, which will be published October ...
Oct 10, 2019
0
5
A new study published in the journal mBio shines light on the breakdown of the blood-brain barrier (BBB) that occurs during many infections of the central nervous system. The findings implicate interferon gamma, a major cytokine ...
Aug 6, 2019
0
11
The Zika virus has affected over 60 million people, mostly in South America. It has potentially devastating consequences for pregnant women and their unborn children, many of whom are born with severe microcephaly and other ...
Jul 25, 2019
0
1
A bacterial pathogen that typically multiplies outside of host cells can enter and induce the destruction of cells called macrophages, according to a study published June 20 in the open-access journal PLOS Pathogens by Anne-Béatrice ...
Jun 20, 2019
0
0
Scientists have discovered yet another way that single-celled organisms have outsmarted us.
May 24, 2019
0
6
Pneumonia starts like this: A bacterial cell called Streptococcus pneumoniae enters the nostril. It travels down the nasal passage and into the lungs, where a war begins. In the lungs, S. pneumoniae encounters immune cells ...
Apr 2, 2019
0
1
Scientists at the Centre for Genomic Regulation (CRG), part of the Barcelona Institute of Science and Technology (BIST), in Barcelona, Spain, have uncovered the biological details of how cells produce a crucial molecule involved ...
Apr 2, 2019
0
2
Autophagy – the process of recycling cellular material in the body, can help combat Salmonella and other pathogens according to researchers at the School of Life Sciences, University of Warwick who have studied how autophagy ...
Mar 26, 2019
0
0
Researchers at the University of Waterloo have developed a new way to prevent and treat Chlamydia, the most common sexually transmitted bacterial infection in the world.
Feb 6, 2019
0
128
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human microbiome-derived bacteria, today announced a publication in ...
Jan 24, 2019
0
3
